# 2-5 Intermittent Caloric Restriction in HIV

> **NCT03489109** · NA · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 35 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Metabolic Syndrome

## Interventions

- **BEHAVIORAL:** Intermittent fasting
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03489109
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-09
- **Primary completion:** 2021-12-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Slow/Insufficient accrual
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489109, "2-5 Intermittent Caloric Restriction in HIV". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03489109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*